Mesentech Inc.
$50,000.00 CAD
≈ 8 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- August 1, 2018 – March 15, 2019
- Reference
- nrc-cnrc:172-2018-2019-Q2-911801
Published purpose
To support upcoming IND filings the firm’s lead candidate bone growth promoting drug will be tested for efficacy in animal (rodent) models, one requiring systemic administration and the other requiring local administration.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions